Literature DB >> 19906082

Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation.

Marco S Folgosa, André Messias, Clécio Takata, Rogério A Costa, Ingrid U Scott, Rodrigo Jorge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19906082     DOI: 10.1111/j.1755-3768.2009.01721.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  2 in total

1.  The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections.

Authors:  Ümit Yolcu; Güngör Sobaci
Journal:  Int Ophthalmol       Date:  2014-11-26       Impact factor: 2.031

2.  Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema.

Authors:  Mehmet Taş; Veysi Oner; Mehmet Fuat Alakuş; Fatih Mehmet Türkcü; Yalçın Işcan; Kemal Yüksel
Journal:  Int Ophthalmol       Date:  2013-01-19       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.